科研製薬(株)
企業情報
機関の空売り残高情報
| 計算日 | 空売り者 | 残高割合 | 増減率 | 残高数量 | 増減量 | 備考 |
|---|---|---|---|---|---|---|
| 2025/06/20 | J.P. Morgan Securities | 0.470% | -0.030% | 211,507株 | -10,400 | 報告義務消失 |
| 2025/06/18 | J.P. Morgan Securities | 0.500% | 0% | 221,907株 | 再IN（前回2025-06-12） | |
| 2025/06/12 | J.P. Morgan Securities | 0.490% | -0.010% | 219,207株 | -1,500 | 報告義務消失 |
| 2025/06/10 | J.P. Morgan Securities | 0.500% | 0% | 220,707株 | 再IN（前回2025-06-03） | |
| 2025/06/03 | J.P. Morgan Securities | 0.490% | -0.350% | 216,407株 | -158,500 | 報告義務消失 |
| 2025/06/02 | J.P. Morgan Securities | 0.840% | 0% | 374,907株 | ||
| 2023/08/30 | Integrated Core Strategies | 0.370% | -0.140% | 172,703株 | -64,737 | 報告義務消失 |
| 2023/08/15 | Integrated Core Strategies | 0.510% | 0% | 237,440株 | 再IN（前回2021-05-27） | |
| 2021/06/02 | GOLDMAN SACHS | 0.470% | -0.050% | 218,765株 | -22,299 | 報告義務消失 |
| 2021/05/27 | Integrated Core Strategies | 0.130% | -0.380% | 60,100株 | -177,700 | 報告義務消失 |
| 2021/05/25 | Integrated Core Strategies | 0.510% | 0% | 237,800株 | ||
| 2021/05/25 | GOLDMAN SACHS | 0.520% | 0% | 241,064株 | 再IN（前回2021-05-18） | |
| 2021/05/18 | GOLDMAN SACHS | 0.440% | -0.060% | 203,865株 | -28,100 | 報告義務消失 |
| 2021/05/13 | GOLDMAN SACHS | 0.500% | 0% | 231,965株 |